In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic

American Journal of Pathology

Volumn 148, Issue 2, 1996, Pages 415-426

  Stieber, Anna ^a   Mourelatos, Zissimos ^a   Gonatas, Nicholas K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIOTIN; POLYCLONAL ANTIBODY; SIALOGLYCOPROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AXOPLASM FLOW; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GOLGI COMPLEX; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MORPHOMETRICS; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN PROCESSING; SENILE PLAQUE;

AGED; ALZHEIMER DISEASE; ENTORHINAL CORTEX; FEMALE; FIBROBLAST GROWTH FACTOR 2; GOLGI APPARATUS; HIPPOCAMPUS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEURITES; NEUROFIBRILLARY TANGLES; NEURONS;

EID: 0030043292     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Farquhar MG, Palade G. The Golgi apparatus (complex) (1951-1981), from artifact to center stage J Cell Biol 1981, 91:77s-103s
2. Farquhar MG Progress in unraveling pathways of Golgi traffic Annu Rev Cell Biol 1985, 1:447-486
3. Hammerschlag R, Stone GC, Bolen FA, Lindsey JD, Ellisman MH: Evidence that all newly synthesized proteins destined for fast axonal transport pass through the Golgi apparatus. J Cell Biol 1982, 93:568-575
4. Amara JF, Cheng SH, Smith AE. Intracellular protein trafficking in human disease T Cell Biol 1992, 2.145-149
5. Terry RD, Gonatas NK, Weiss M: Ultrastructural studies in Alzheimer's presenile dementia. Am J Pathol 1964, 44.269-297
6. Kosik KS: The Alzheimer's disease sphinx: a riddle with plaques and tangles J Cell Biol 1994, 127:1501-1504
7. St. George-Hyslop PH, Haines JL, Farrer LA, et al. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature 1990, 347 194-197
8. Tanzi R, Gaston S, Bush A, Romano D, Pettingell W, Peppercorn J, Paradis M, Gurubhagavatula S, Jenkins B, Wasco W. Genetic heterogeneity of gene defects responsible for familial Alzheimer disease Genetica 1993, 91:255-263
9. Mourelatos Z, Adler H, Hirano A, Donnenfeld H, Gonatas JO, Gonatas NK: Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis revealed by organelle-specific antibodies Proc Natl Acad Sci USA 1990, 87:4393-4395
10. Gonatas NK, Stieber A, Mourelatos Z, Chen Y, Gonatas JO, Appel SH, Hays AP, Hickey WF, Hauw JJ: Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis Am J Pathol 1992, 140:731-737
11. Mourelatos Z, Yachnis A, Rorke L, Mikol J, Gonatas NK The Golgi apparatus of motor neurons in amyotrophic lateral sclerosis Ann Neurol 1993, 33:608-615
12. Lucassen PJ, Ravid R, Gonatas NK, Swaab DF Activation of the human supraoptic and paraventricular neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus Brain Res 1993, 632: 105-113
13. Gonatas NK: Contributions to the physiology and pathology of the Golgi apparatus Am J Pathol 1994, 145.751-761
14. Mourelatos Z, Hirano A, Rosenquist A, Gonatas NK. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis (ALS): clinical studies in ALS of Guam and experimental studies in deafferented neurons and in β,β-iminodiproprionitrile axonopathy Am J Pathol 1994, 144:1288-1300
15. Lucassen PJ, Salehi A, Pool CW, Gonatas NK, Swaab DF: Activation of vasopressin neurons in aging and Alzheimer's disease J Neuroendocrinol 1994, 6:673-679
16. Salehi A, Lucassen PJ, Pool CW, Gonatas NK, Ravid R, Swaab DF. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience 1994, 59:871-880
17. Salehi A, Van de Nes JAP, Hofman MA, Gonatas NK, Swaab DF: Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity. Brain Res 1995, 678:29-39
18. Salehi A, Heyn S, Gonatas NK, Swaab DF. Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by smaller Golgi apparatus Neurosci Lett 1995, 193.29-32
19. Tascos A, Mourelatos Z, Gonatas NK. On the significance and reproducibility of the fragmentation of the Golgi apparatus of motor neurons in human spinal cords. J Neuropathol Exp Neurol 1995, 54 331-338
20. Salehi A, Ravid R, Gonatas NK, Swaab DF. Decreased activity of hippocampal neurons in Alzheimer's disease is not related to the presence of Neurofibrillary Tangles J Neuropathol Exp Neurol 1995, 54.704-709
21. Gonatas JO, Mezitis SGE, Stieber A, Fleischer B, Gonatas NK. MG-160 a novel sialoglycoprotein of the medial cisternae of the Golgi apparatus J Biol Chem 1989, 264.546-653
22. Mourelatos Z, Gonatas, JO, Nycum LM, Gonatas NK, Siegel JA: Assignment of the GLG1 gene for MG-160, a fibroblast growth factor and E-selectin binding membrane sialoglycoprotein of the Golgi apparatus, to chromosome 16q22-23 by fluorescence in situ hybridization. Genomics 1995, 28:354-355
23. Stieber A, Mourelatos Z, Chen Y-J, Le Douarin N, Gonatas NK: MG160, a membrane protein of the Golgi apparatus which is homologous to a fibroblast growth factor receptor, and to a ligand for E-selectin, is found only in the Golgi apparatus, and appears early in chicken embryo. Exp Cell Res 1995, 219.562-570
24. Johnston PA, Stieber A, Gonatas NK: A hypothesis on the traffic of MG160, a medial Golgi sialoglycoprotein, from the trans-Golgi network to the Golgi cisternae. J Cell Sci 1994, 107.529-537
25. Burrus LW, Zuber ME, Lueddecke BA, Olwin BB. Identification of a cysteine-rich receptor for fibroblast growth factors. Mol Cell Biol 1992, 12:5600-5609
26. Zhou Z, Olwin BB: Characterization of the FGF binding domain of the cysteine-rich FGF receptor Mol Biol Cell 1994, 5:136a
27. Steegmaier M, Levinovitz A, Isenmann S, Borges E, Lenter M, Kocher HP, Kleuser B, Vestweber D: The E-selectin ligand ESL-1 is a variant of a receptor for fibroblast growth factor Nature 1995, 373:615-620
28. Gonatas JO, Mourelatos Z, Stieber A, Lane WS, Brosius J, Gonatas NK MG-160, a membrane sialoglycoprotein of the medial cisternae of the rat Golgi apparatus, binds basic fibroblast growth factor and exhibits a high level of sequence identity to a chicken fibroblast growth factor receptor. J Cell Sci 1995, 108 457-467
29. Croul S , Mezitis SGE, Stieber A, Chen Y, Gonatas JO, Goud B, Gonatas NK: Immunocytochemical visualization of the Golgi apparatus in several species, including human, and tissues with an antiserum against MG-160, a sialoglycoprotein of the rat Golgi apparatus J Histochem Cytochem 1990, 38:957-963
30. Dal Canto, MC, Gonatas NK, Chiu AY, Gurney ME: Neuropathological changes in two lines of mice carrying a transgene for mutant Cu,Zn, SOD, and in mice overexpressing wild-type human SOD A model of familial amyotrophic lateral sclerosis (FALS). J Neuropathol Exp Neurol 1995, 54:442
31. Jasmin BA, Anthony C, Changeux J-P, and Cartaud J: Nerve dependent plasticity of the Golgi complex in skeletal muscle fibres: compartmentalization within the subneural sarcoplasm. Eur J Neurosci 1995, 7:470-479
32. Kato T, Sasaki H, Katagiri T, Sasaki H, Kotwai K, Youki H, Totsuka S, Ishii T. The binding of basic fibroblast growth factor to Alzheimer's neurofibrillary tangles and senile plaques Neurosci Lett 1991, 122:33-36
33. Siedlak SL, Cras P, Kawai M, Richey P, Perry G: Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease. J Histochem Cytochem 1991, 39:899-904
34. Stopa EG, Gonzalez AM, Chorsky R, Corona RJ, Alvarez J, Bird ED, Baird A: Basic fibroblast growth factor in Alzheimer's disease. Biochem Biophys Res Commun 1990, 171:690-696
35. Burgess WH, Maciag T: The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989, 58:575-606
36. Perry G, Siedlak SL, Richey P, Kawai M, Cras P, Kalaria RN, Galloway PG, Scardina JM, Cordell B, Greenberg BD, Ledbetter SR, Gambetti P Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease. J Neurosci 1991, 11:3679-3683
37. Snow AD, Mar H, Nochlin D, Kimata K, Kato M, Suzuki S, Hassell J, Wight TN: The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol 1988, 133 456-463
38. Snow AD, Sekiguchi R, Nochlin D, Fraser P, Kimata K, Mizutani A, Arai M, Schreier WA, Morgan DG: An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain Neuron 1994, 12.219-234
39. Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K: Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain Am J Pathol 1994, 144:337-347
40. Cummings BJ, Su JH, Cotman CW Neuritic involvement with bFGF immunopositive plaques of Alzheimer's disease. Exp Neurol 1993, 124:315-325
41. Shi S-R, Key ME, Kalra KL Antigen retrieval in formalin-fixed, paraffin embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections J Histochem Cytochem 1991, 39:741-748
42. Torack RM, Morris JC: Mesolimbocortical dementia. A clinicopathologic case study of a putative disorder Arch Neurol 1986, 43:1074-1078
43. Knopman DS, Mastri AR, Frey WH II, Sung JH, Rustan T: Dementia lacking distinctive histologic features, a common non-Alzheimer degenerative dementia. Neurology 1990, 40:251-256
44. Corsellis, JAN The limbic areas in Alzheimer's disease and in other conditions associated with dementia. Alzheimer's Disease. A Ciba Foundation Symposium. Edited by GEW Wolstenholme, M O'Connor. London, JA Churchill, 1970, pp 37-45.
45. Davies DC, Horwood N, Isaacs SL, Mann DMA: The effect of age and Alzheimer's disease in the individual fields of the hippocampal formation Acta Neuropathol 1992, 83:510-517
46. Bobinsky M, Wegiel J, Tarnawski M, DeLeon MJ, Dziewiatkowski J, Wisniewski HM Computer-assisted 3D-reconstruction of the hippocampal formation in AD J Neuropathol Exp Neurol 1993, 52:263
47. Tomlinson BE, Blessed G, Roth M Observations on the brains of demented old people. J Neurol Sci 1970, 11:205-242
48. Gonatas NK: Axonic and synaptic lesions in neuropsychiatric disorders. Nature 1967, 214 352-355
49. Gonatas NK, Anderson W, Evangelista I The contribution of altered synapses in the senile plaque: an electron microscope study in Alzheimer's dementia J Neuropathol Exp Neurol 1967, 26:25-39
50. Gonatas NK, Gambetti P: The pathology of the synapse in Alzheimer's disease. Alzheimer's Disease. A Ciba Foundation Symposium. Edited by GEW Wolstenholme, M O'Connor. London, JA Churchill, 1970, pp 169-183
51. Baird A: Fibroblast growth factors activities and significance of non-neurotrophic growth factors Curr Opin Neurobiol 1994, 4:78-86
52. Morrison, RS: Suppression of basic fibroblast growth factor expression by antisense oligonucleotides inhibits the growth of transformed human astrocytes J Biol Chem 1991, 266:728-734
53. Rifkin DB, Moscatelli D: Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989, 109:1-6
54. Zagzag D, Miller DC, Sato Y, Rifkin DB, Burstein DE. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 1990, 50:7393-7398
55. Sensenbrenner, M The neurotrophic activity of fibroblast growth factors. Prog Neurobiol 1993, 41:683-704
56. Anderson KJ, Dam D, Lee S, Cotman CW: Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo Nature 1988, 332 360-361
57. Gomez-Pinilla F, Lee JW, Cotman CW: Basic FGF in adult rat brain cellular distribution and response to entorhinal lesion of fimbria-fornix transection J Neurosci 1992, 12:345-355
58. Kohmura E, Yuguchi T, Yamada K, Sakaguchi T, Hayakawa T Basic fibroblast growth factor prevents retrograde degeneration of the thalamic neurons after ablation of somatosensory cortex. Recent Adv Neurotramatol 1993, 260-263
59. Yuguchi T, Kohmura E, Yamada K, Wanaka A, Otsuki H, Sakaaguchi T, Yamashita T, Tohyama M, Hayakawa T. Messenger RNA, and protein expression of basic fibroblast growth factor receptor after cortical ablation. Mol Brain Res 1994, 25:50-56
60. Ray J, Cage FH: Spinal cord neuroblasts proliferate in response to basic fibroblast growth factor J Neurosci 1994, 14:3548-3564
61. Eckenstein F, Woodward WR, Nish R: Differential localization and possible functions of aFGF and bFGF in the central and peripheral nervous systems. Ann NY Acad Sci 1991, 638:348-360
62. Ledoux D, Mereau A, Jaye M, Miskulin M, Barritault D, Court J Adult brain but not kidney, liver, lung, intestine, and stomach membrane preparations contain detectable amounts of high-affinity receptors to acidic and basic growth factors. Ann NY Acad Sci 1991, 638 397-398
63. Kiefer P, Peters G, Dickson C. Retention of fibroblast growth factor 3 in the Golgi complex may regulate its export from cells Mol Cell Biol 1993, 13:5781-5793
64. Masliah E, Terry RD: The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol 1993, 3:77-85
65. Baird A, Schubert D, Ling N, Guillemin R. Receptor-and heparin-binding domains of basic fibroblast growth factor Proc Natl Acad Sci USA 1988, 85:2324-2328
66. Ellisman M, Ranganathan R, Deerick T, Young S, Terry R, Mirra S. Neuronal fibrillar cytoskeleton and endomembrane system organization in Alzheimer's disease Alterations in the Neuronal Cytoskeleton in Alzheimer's Disease. Edited by G Perry New York, Plenum Publishing Co. 1987, pp 61-73
67. Kidd M: Paired helical filaments in electron microscopy of Alzheimer's disease. Nature. 1963, 197:192-193
68. Matsuo ES, Shin R-W, Billingsley ML, Van deVoorde A, O'Connor K, Trojanowski JQ, Lee V M-Y Biopsy-derived adult human brain Tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament Tau. Neuron 1994, 13:989-1002
69. Bondareff W, Harrington CR, Wishik CM, Hauser DL, Roth M Absence of abnormal hyperphosphorylation of Tau in intracellular tangles in Alzheimer's disease J Neuropathol Exp Neurol 1995, 54:657-663
70. Smith MA, Taneda S, Richey PL, Miyata S, Yan S-D, Stern D, Sayre LM, Monnier VM, Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology Proc Natl Acad Sci USA 1994, 91 5710-5714
71. Su JH, Anderson AJ, Cummings BJ, and Cotman CW: Immunohistochemical evidence for apoptosis in Alzheimer's disease Clin Neurosci Neuropathol 1994, 5:2529-2533
72. Swaab DF, Hofman MA, Lucaassen PJ, Salehi A, Uylings HB Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease. Neurobiol Aging 1994, 15:369-371
73. Regeur L, Jensen GB, Pakkenberg H, Evans SM, Pakkenberg B. No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type. Neurobiol Aging 1994, 15:347-352
74. Robbins E, Gonatas NK: Histochemical and ultrastructural studies on HeLa cell cultures exposed to spindle inhibitors with special reference to the interphase cell J Histochem Cytochem 1964, 12:704-711
75. Turner JR, Tartakoff AM: The response of the Golgi complex to microtubule alterations: the roles of metabolic energy and membrane traffic in Golgi complex organization. J Cell Biol 1989, 109:2081-2088
76. Lacy PE, Howell SL, Young DA, Fink CJ: New hypothesis of insulin secretion. Nature 1968, 219:1177-1179
77. Antoine SC, Maurice M, Feldman G, Avrameas S. In vivo and in vitro effects of colchicine and vinblastine on the secretory process of antibody-producing cells. J Immunol 1980, 125 1939-1949